Oncogenic Viruses and Hepatocellular Carcinoma

被引：20
|
作者：
Ben Ari, Ziv [1 ,2 ,3 ]
Weitzman, Ella [1 ,3 ]
Safran, Michel [1 ,2 ]
机构：
[1] Chaim Sheba Med Ctr, Liver Dis Ctr, IL-52621 Ramat Gan, Israel
[2] Chaim Sheba Med Ctr, Liver Res Lab, IL-52621 Ramat Gan, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源：
CLINICS IN LIVER DISEASE | 2015年 / 19卷 / 02期
关键词：
Hepatocellular carcinoma; Oncogenic viruses; Hepatitis B; Hepatitis C; HEPATITIS-C-VIRUS; SUSTAINED VIROLOGICAL RESPONSE; NONSTRUCTURAL PROTEIN NS3; E-CADHERIN EXPRESSION; X-PROTEIN; LONG-TERM; CORE PROTEIN; ANTIVIRAL THERAPY; NONCIRRHOTIC PATIENTS; INTERFERON THERAPY;
D O I：
10.1016/j.cld.2015.01.006
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
About 80% of hepatocellular carcinoma (HOC) is caused by hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections especially in the setting of established cirrhosis or advanced fibrosis, making HOC prevention a major goal of antiviral therapy. HOC tumors are highly complex and heterogeneous resulting from the aberrant function of multiple molecular pathways. The roles of HCV or HBV in promoting HOC development are still either directly or indirectly are still speculative, but the evidence for both effects is compelling. In patients with chronic hepatitis viral infection, cirrhosis is not a prerequisite for tumorigenesis.
引用
收藏
页码：341 / +
页数：21
相关论文
共 50 条
  • [21] Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
    Swamy, Supritha G.
    Kameshwar, Vivek H.
    Shubha, Priya B.
    Looi, Chung Yeng
    Shanmugam, Muthu K.
    Arfuso, Frank
    Dharmarajan, Arunasalam
    Sethi, Gautam
    Shivananju, Nanjunda Swamy
    Bishayee, Anupam
    TARGETED ONCOLOGY, 2017, 12 (01) : 1 - 10
  • [22] Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma
    Yu, Gyung-Ran
    Kim, Seong-Hun
    Park, Seon-Hwa
    Cui, Xiang-Dan
    Xu, Dong-Yuan
    Yu, Hee-Chul
    Cho, Baik-Hwan
    Yeom, Young-Il
    Kim, Sang-Soo
    Kim, Sang-Bae
    Chu, In-Sun
    Kim, Dae-Ghon
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2007, 39 (05): : 641 - 652
  • [23] ONCOGENIC VIRUSES
    GREEN, M
    ANNUAL REVIEW OF BIOCHEMISTRY, 1970, 39 : 701 - +
  • [24] Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma
    Tanaka, S
    Sugimachi, K
    Maehara, S
    Harimoto, N
    Shirabe, K
    Wands, JR
    Sugimachi, K
    SURGERY, 2002, 131 (01) : S142 - S147
  • [25] The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
    Wu, Zhixian
    Cheng, Hongwei
    Liu, Jie
    Zhang, Shuaishuai
    Zhang, Minda
    Liu, Fangzhou
    Li, Yinghui
    Huang, Qian
    Jiang, Yi
    Chen, Shaohua
    Lv, Lizhi
    Li, Dongliang
    Zeng, Jin-Zhang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 141 - 155
  • [26] ONCOGENIC VIRUSES
    WYKE, JA
    JOURNAL OF PATHOLOGY, 1981, 135 (01): : 39 - 85
  • [27] ONCOGENIC VIRUSES
    ECKHART, W
    ANNUAL REVIEW OF BIOCHEMISTRY, 1972, 41 : 503 - &
  • [28] ONCOGENIC VIRUSES
    BECKER, Y
    FEBS LETTERS, 1980, 111 (01) : 258 - 258
  • [29] ONCOGENIC VIRUSES
    不详
    NATURE, 1972, 236 (5340) : 14 - &
  • [30] ONCOGENIC VIRUSES
    BECKER, Y
    FEBS LETTERS, 1980, 110 (02) : 358 - 358
12345